Literature DB >> 2817844

Neuropathological changes in early HIV-1 dementia.

J C McArthur1, P S Becker, J E Parisi, B Trapp, O A Selnes, D R Cornblath, J Balakrishnan, J W Griffin, D Price.   

Abstract

Early pathological abnormalities in human immunodeficiency virus (HIV-1)-related dementia have not been well documented. We report a homosexual man with fatigue and intermittent diarrhea in whom early HIV-1-related dementia was demonstrated during neurological screening in the Multicenter AIDS Cohort Study. Within 4 months he died of massive epistaxis, and the brain revealed astrocytosis of white matter and mild pallor of myelin staining in the absence of inflammation, multinucleated giant cells, and brain atrophy.

Entities:  

Mesh：

Year:  1989        PMID： 2817844     DOI： 10.1002/ana.410260516

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


  13 in total

1.  Infection of primary human microglia and monocyte-derived macrophages with human immunodeficiency virus type 1 isolates: evidence of differential tropism.

Authors:  J M Strizki; A V Albright; H Sheng; M O'Connor; L Perrin; F González-Scarano
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

Review 2.  In vivo modeling of HIV-1 mediated neurodegeneration.

Authors:  E Masliah
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

3.  Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate.

Authors:  J Martín; C C LaBranche; F González-Scarano
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

Review 4.  [HIV 1-associated neurocognitive disorder: current epidemiology, pathogenesis, diagnosis and management].

Authors:  C Eggers
Journal:  Nervenarzt       Date:  2014-10       Impact factor: 1.214

5.  Common immunologic determinant between human immunodeficiency virus type 1 gp41 and astrocytes.

Authors:  M Yamada; A Zurbriggen; M B Oldstone; R S Fujinami
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

6.  The reverse transcriptase sequence of human immunodeficiency virus type 1 is under positive evolutionary selection within the central nervous system.

Authors:  Kelly J Huang; Gerald M Alter; Dawn P Wooley
Journal:  J Neurovirol       Date:  2002-08       Impact factor: 2.643

7.  Changes in MRS neuronal markers and T cell phenotypes observed during early HIV infection.

Authors:  M R Lentz; W K Kim; V Lee; S Bazner; E F Halpern; N Venna; K Williams; E S Rosenberg; R G González
Journal:  Neurology       Date:  2009-04-28       Impact factor: 9.910

8.  Low levels of human immunodeficiency virus replication in the brain tissue of children with severe acquired immunodeficiency syndrome encephalopathy.

Authors:  R Vazeux; C Lacroix-Ciaudo; S Blanche; M C Cumont; D Henin; F Gray; L Boccon-Gibod; M Tardieu
Journal:  Am J Pathol       Date:  1992-01       Impact factor: 4.307

9.  Dysregulation of signal transduction pathways as a potential mechanism of nervous system alterations in HIV-1 gp120 transgenic mice and humans with HIV-1 encephalitis.

Authors:  T Wyss-Coray; E Masliah; S M Toggas; E M Rockenstein; M J Brooker; H S Lee; L Mucke
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

10.  HIV-1 Tat and morphine have interactive effects on oligodendrocyte survival and morphology.

Authors:  Kurt F Hauser; Yun Kyung Hahn; Valeriya V Adjan; Shiping Zou; Shreya K Buch; Avindra Nath; Annadora J Bruce-Keller; Pamela E Knapp
Journal:  Glia       Date:  2009-01-15       Impact factor: 7.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.